The pharmaceutical company Sanofi announced on March 16 that will reduce up to 78% the priceor its most prescribed insulin product in the United States, joining two other major producers of the drug that have announced similar measures in recent weeks. Sanofi will invest 19 million dollars in Mexico in research and therapies Read more … Read more
Researchers are fiercely discussing what led to the adaptation of corona vaccines to the BA.5 variant. While vaccine makers Biontech and Moderna are touting the benefits of the new bivalent booster vaccines, a new independent laboratory study by researchers in Göttingen and Hanover now suggests that while there is an additional benefit from the upgrade, … Read more
Frankfurt am Main skyline Frankfurt was particularly affected by the crown pandemic: jobs were cut at both Frankfurt Airport and at the Frankfurt Messe. (Photo: imago images / Jan Eifert) From his workplace at the Old Stock Exchange, Ulrich Caspar looks directly at the forecourt with the bull and bear sculptures. The trade hall of … Read more
If the math functions, China and India could make a actual breakthrough from the corona virus this time all around. For the initial time, equally nations have authorised vaccines that are used straight to the mucous membranes of the respiratory tract, somewhat than injected into muscle mass tissue like the mRNA vaccines made use of … Read more
news by Ilse Romahn (03.08.2022) City Councilor Stephanie Wüst continued her company talks in Industriepark Höchst with a visit to the healthcare company Sanofi Germany, the largest industrial company in Frankfurt am Main and also the largest location of the French group worldwide. – ‹ › – Ralph Hug, Head of Political Communication, Sanofi-Aventis Deutschland … Read more
Strategic independence on health products, public support and European production. The project, announced two years ago, ticks all the boxes in the current circumstances. Sanofi clarified the terms on Friday, April 1. Its subsidiary Euroapi, which produces the active ingredients of drugs – that is to say the molecules providing their therapeutic properties – will … Read more
Sanofi’s Covid vaccine is not for now. the French pharmaceutical giant is still awaiting the results of its latest clinical trial (phase 3), planned during the first quarter of 2022, to request a possible marketing authorization from the health authorities of the various countries. Read also: Covid-19. New delay for the French Sanofi vaccine: will … Read more
Posted on Friday, December 10, 2021 Sanofi announced that the New England Journal of Medicine (NEJM) published the positive results of a pivotal trial of Dupixent® (dupilumab) in the treatment of moderate to severe uncontrolled asthma in children aged 6 to 11 years old. These data motivated the approval that the FDA granted on October … Read more
In the race to supply vaccines to combat the COVID-19 pandemic, US drug manufacturer Novavax has headed to emerging Europe to accelerate production with more transactions in addition to the consolidation trend in the region, Reuters reports. In these transactions, which were stimulated by a combination of private equity firms and those in the big … Read more
Laggard pharmaceuticals could be about to receive a post-pandemic booster shot. The actions of GlaxoSmithKline, Novartis or Sanofi have suffered during the confinements, as routine procedures and treatments have been postponed. But with the economic reopening they should recover. The health sector has had its share of winners for Covid, such as Moderna. But some … Read more